Amicus Therapeutics
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Globeside Business Park, Fieldhouse Lane...Phone Number
+44 1753888567Website
www.amicusrx.co.ukRevenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Amicus Therapeutics
Amicus Therapeutics, Inc. is a biotechnology company headquartered in the USA that develops treatments for human genetic diseases. A wholly owned subsidiary of BioMarin Pharmaceutical Inc., the company focuses on delivering medicines for people living with genetically defined conditions, specifically targeting rare and orphan diseases. Amicus Therapeutics leverages technology platforms to advance a pipeline of medicines for metabolic diseases, serving patients and disease communities through the development of first- or best-in-class therapies.Explore more
Popular SearchesAmicus Therapeutics IncAmicus CorpAmicus Therapeutics UK LtdSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amicus Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Amicus Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Amicus Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Amicus Therapeutics recently announced quarterly report
Check out if Amicus Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Amicus Therapeutics
Product Launch: Get notified when Amicus Therapeutics launches new products
Click to see if Amicus Therapeutics had a recent Job posting/layoffs
Amicus Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Amicus Therapeutics
Compare insights from companies similar to Amicus Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Amicus Therapeutics
$5.9M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Amicus Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amicus Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amicus Therapeutics.
Amicus Therapeutics Tech Stack
A closer look at the technologies used by Amicus Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amicus Therapeutics
Sign Up For FreeTo access detailed company insights
Amicus Therapeutics, Inc. is a biotechnology company headquartered in the USA that develops treatments for human genetic diseases. A wholly owned subsidiary of BioMarin Pharmaceutical Inc., the company focuses on delivering medicines for people living with genetically defined conditions, specifically targeting rare and orphan diseases. Amicus Thera... Read More
